(NASDAQ: OFIX) Orthofix Medical's forecast annual revenue growth rate of 4.78% is not forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 8.42%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 14.06%.
Orthofix Medical's revenue in 2026 is $825,374,000.On average, 7 Wall Street analysts forecast OFIX's revenue for 2026 to be $34,786,469,495, with the lowest OFIX revenue forecast at $33,180,113,044, and the highest OFIX revenue forecast at $36,288,538,083. On average, 7 Wall Street analysts forecast OFIX's revenue for 2027 to be $36,590,892,040, with the lowest OFIX revenue forecast at $34,562,533,543, and the highest OFIX revenue forecast at $38,622,888,486.
In 2028, OFIX is forecast to generate $38,374,699,543 in revenue, with the lowest revenue forecast at $35,869,769,768 and the highest revenue forecast at $40,358,190,006.